YUK-15627-60030 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-05-15
Dose 1 — Pfizer-BioNTech
2021-06-10
Dose 2 — Pfizer-BioNTech
2022-01-10
Dose 3 — Pfizer-BioNTech
2022-09-09
Dose 4 — Other-Unknown
2022-09-17
Registered in v-safe
2022-09-17
Health check-in — 7 day, dose 4, dependent
Feeling: Good · None

Adult check-in
2022-09-23
Health check-in — 14 day, dose 4, dependent
Feeling: Good

Adult check-in
2022-10-01
Health check-in — 21 day, dose 4, dependent
Feeling: Good

Adult check-in
2022-10-07
Health check-in — 28 day, dose 4, dependent
Feeling: Good

Adult check-in
2022-10-16
Health check-in — 35 day, dose 4, dependent
Feeling: Good

Adult check-in
2022-10-22
Health check-in — 42 day, dose 4, dependent
Feeling: Good

Adult check-in
2022-12-10
Health check-in — 3 month, dose 4, dependent
Feeling: Good

Adult check-in
2023-03-10
Survey response — 6 month, dose 4, dependent
MedDRA: Body temperature decreased, Fatigue, Malaise, Oropharyngeal pain — Feeling: Poor · Be unable to work or attend school

MedDRA releases: 2024-11 · check-in answers available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-05-15	Pfizer-BioNTech	No
2	2021-06-10	Pfizer-BioNTech	No
3	2022-01-10	Pfizer-BioNTech	No
4	2022-09-09	Other-Unknown	No

Free text

None.

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Body temperature decreased	·	·	✓
SD	Fatigue	·	·	✓
SD	Malaise	·	·	✓
SD	Oropharyngeal pain	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release